United Therapeutics (UTHR) Tops Estimates, Posts Q3 $0.66
UTHR Hot Sheet
EPS Growth %: +2.3%Financial Fact:
Equity loss in affiliate: -20K
Today's EPS Names:
SAPX, ECTY, TRNS, More
United Therapeutics (NASDAQ: UTHR) reports Q3 EPS of $0.66, versus the analyst estimate of $0.30. Revenue for the quarter was $97.22 million, which compares to the estimate of $90.20 million.
You May Also Be Interested In
- UPDATE: Lowe's (LOW) Beats Q1 Views Amid Lagging Seasonal Demand; Issues Light FY12 Earnings Outlook
- Ecotality, Inc. (ECTY) Posts Surprise Q1 Profit
- Trunkbow International Holdings (TBOW) Posts Mixed Q1 Results
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
